Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.1 USD | +1.11% | +3.12% | -15.14% |
05-09 | Transcript : Oncternal Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Oncternal Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.14% | 26.93M | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+45.26% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- ONCT Stock
- News Oncternal Therapeutics, Inc.
- Oncternal Therapeutics : Brookline Capital Initiates Coverage on Oncternal Therapeutics With Buy Rating, $16 Price Target